No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation

Veronica H. Flood, Kenneth D. Friedman, Joan Cox Gill, Sandra L. Haberichter, Pamela A. Christopherson, Brian R. Branchford, Raymond G. Hoffmann, Thomas C. Abshire, Amy L. Dunn, Jorge A. Di Paola, W. Keith Hoots, Deborah L. Brown, Cindy Leissinger, Jeanne M. Lusher, Margaret V. Ragni, Amy D. Shapiro, Robert R. Montgomery

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


The diagnosis of von Willebrand disease (VWD) is complicated by issues with current laboratory testing, particularly the ristocetin cofactor activity assay (VWF:RCo). We have recently reported a sequence variation in the von Willebrand factor (VWF) A1 domain, p.D1472H (D1472H), associated with a decrease in the VWF:RCo/VWF antigen (VWF:Ag) ratio but not associated with bleeding in healthy control subjects. This report expands the previous study to include subjects with symptoms leading to the diagnosis of type 1 VWD. Type 1 VWD subjects with D1472H had a significant decrease in the VWF:RCo/VWF:Ag ratio compared with those without D1472H, similar to the findings in the healthy control population. No increase in bleeding score was observed, however, for VWD subjects with D1472H compared with those without D1472H. These results suggest that the presence of the D1472H sequence variation is not associated with a significant increase in bleeding symptoms, even in type 1 VWD subjects.

Original languageEnglish
Pages (from-to)3742-3744
Number of pages3
Issue number18
StatePublished - May 2 2013


Dive into the research topics of 'No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation'. Together they form a unique fingerprint.

Cite this